Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

GE Healthcare

BioPhotonics
Aug 2008
GE Healthcare of Little Chalfont, UK, along with VTT Technical Research Centre of Finland in Espoo and other European research institutions, has announced the PredictAD project, a collaboration that will research diagnostic procedures for patients with Alzheimer’s disease. The European Union-funded project will study imaging biomarkers, electronic brain activity and blood-based markers in hopes of finding ways to diagnose the disease at an earlier stage, to differentiate between its various forms and to assess its severity.

In other news, GE Healthcare and the University of Pittsburgh Medical Center have formed a company to improve the speed and efficiency of the diagnosis and interpretation of laboratory results. The joint venture, called Omnyx LLC, will be based in Pittsburgh and will focus on digital imaging solutions.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!